Sims Strategies, LLC
Sims Strategies, LLC is a lobbying firm that has earned $11.1M in lobbying income across 238 filings, representing 19 clients over 8 years (2018–2025). The firm employs 2 lobbyists across 13 policy issue areas.
🤖
AI Overview
Sims Strategies, LLC has earned $11.1M in lobbying income across 238 filings, representing 19 clients. It is a significant player in the federal lobbying industry. across 13 policy areas. Active from 2018 to 2025.
$11.1M
Total Income
19
Clients
2
Lobbyists
238
Filings
Income by Year
| Year | Lobbying Income |
|---|---|
| 2018 | $995K |
| 2019 | $1.2M |
| 2020 | $1.4M |
| 2021 | $1.7M |
| 2022 | $2.0M |
| 2023 | $1.6M |
| 2024 | $1.2M |
| 2025 | $1.0M |
Clients (19)
Advion (Formerly National Association for the Support of Long Term Care)Glaxosmithkline, INC.Amag PharmaceuticalWellcare Health Plans, INC.Juul Labs, INC.Academy of Adoption and Assisted Reproduction Attorneys (FKA Am Ac Adpt Attnys)Connect 4 Strategies, LLC (on Behalf of Recordati Rare Diseases)US Physician Partners (Informal Coalition)Orchard Therapeutics North AmericaPhysicians for Fair CoverageSidecar Health, INC.Creighton UniversityEnvista Holdings CorporationTherapeuticsmd, INC.Chronic Care Policy AllianceBoehringer Ingelheim Pharmaceuticals, INC.Alliance of Community Health PlansClear Spring Health Management Services, LLCStand With Ivf
Lobbyists (2)
Issue Areas (13)
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.